Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: saszu who wrote (21670)	5/6/1999 12:26:00 AM
From: VLAD	Respond to of 23519

You forgot to mention that one of their board members is the richest man in the world and owns something like 13% of the common stock. But so what! Fact of the matter is that ICOS never made a dime on product sales because they never have carried a product from the R&D stage to market. They have only managed to burn through millions of $$$ and are estimated to lose $1.32/share in 1999 and $2.14/share in 2000. And then tell me that the fair market value of Vivus is $5 3/16. Bottom line folks is that we own a MANIPULATED stock. Find me one small cap biotech company(other than Vivus) that has a FDA approved product selling in international markets and a decent R&D pipeline that is trading at 5 bucks. You can't because there are none! Joke is on us I guess.